COVID: Michigan cases fall; panel to meet to discuss J&J vaccine pause
More than a week after the Centers for Disease Control and Prevention and the Food and Drug Administration recommended a pause on the one-shot Johnson & Johnson vaccine due to reports of severe blood clots, a government advisory committee will meet again Friday to discuss next steps. "I want this vaccine back as soon as possible," said Dr. Amesh Adalja, an infectious disease expert and senior scholar with the Johns Hopkins University Center for Health Security. "I was recommending it preferentially to my friends. One and done." The vaccine was paused after reports of a rare combination ...